The journal will seek to provide practical information for the entire healthcare team treating and caring for patients inside the pharmacy and retail clinics.
As primary care expands to provide optimal access to quality care, Inside Patient Care: Pharmacy & Clinics will offer a forum for the team treating and coordinating patient care in pharmacies and retail clinics, including pharmacists, medical directors, physician assistants, nurse practitioners, and C-level executives, to implement their best therapeutic options, navigate the healthcare system, and achieve professional success.
As primary care expands to provide optimal access to quality care, Inside Patient Care: Pharmacy & Clinics will offer a forum for the team treating and coordinating patient care in pharmacies and retail clinics, including pharmacists, medical directors, physician assistants, nurse practitioners, and C-level executives, to implement their best therapeutic options, navigate the healthcare system, and achieve professional success.
The US Food and Drug Administration (FDA) is preparing to survey pharmacists and patients on variations in the physical characteristics of generic drugs and patient perceptions. This is important to retail pharmacy, since approximately 85% of all prescriptions dispensed are generic medications.
Ever since the first case of Ebola in the United States was confirmed on September 30, 2014, the country has been on heightened alert about the possibility of an outbreak of the virus.
International travel has been increasing exponentially over the years, and it will continue to increase with the number of international tourists expected to reach 1.6 billion by 2020.
With influenza activity peaking between December and February, it is important for patients to be aware of the following tips to reduce their risk for catching the flu.
In a recent interview with Inside Patient Care: Pharmacy & Clinics, Jonathan L. Temte, MD, PhD, Chair of the US Advisory Committee on Immunization Practices, discusses the role of the committee and the importance of pharmacists and retail clinicians in immunization.
I am Privileged to still be seeing patients in our primary care practice within the Division of Internal Medicine at Sidney Kimmel Medical College (formerly Jefferson Medical College). Parenthetically, I am also the oldest physician in the group. Like many primary care physicians, I have recently seen an increase in the number of patients who bring results of proprietary genetic testing to the office. These results, often from companies such as 23andMe, a DNA analysis service, represent a sea change in at least one aspect of the doctor–patient relationship.
In recent years, the US healthcare system has been shifting from a fee-for-service system to a value-driven system.
When working in healthcare, quality is always being measured. There are many acronyms, measures, and surveys that are used in everyday conversations in pharmacy. You may hear “HCAHPS,” “Star Rating,” “PDC,” adherence rates, readmission rates—the list goes on and on—and you find yourself asking: “What do these measurements mean? What are they based on?”
One of the most talked about topics in our industry right now is the growth of specialty pharmacy. The cost of many specialty medications has employers and health plans scrambling for answers on how to best manage their growing specialty drug expenditure.
